China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction... Show more
a developer of traditional chinese medicines
Industry PharmaceuticalsGeneric
A.I.dvisor indicates that over the last year, SXTC has been loosely correlated with AQST. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if SXTC jumps, then AQST could also see price increases.
| Ticker / NAME | Correlation To SXTC | 1D Price Change % | ||
|---|---|---|---|---|
| SXTC | 100% | +5.95% | ||
| AQST - SXTC | 53% Loosely correlated | -1.88% | ||
| SNDL - SXTC | 28% Poorly correlated | -2.05% | ||
| PCRX - SXTC | 25% Poorly correlated | -3.09% | ||
| GELS - SXTC | 25% Poorly correlated | -0.14% | ||
| BHC - SXTC | 24% Poorly correlated | -5.65% | ||
More | ||||
| Ticker / NAME | Correlation To SXTC | 1D Price Change % |
|---|---|---|
| SXTC | 100% | +5.95% |
| Pharmaceuticals: Generic industry (83 stocks) | 55% Loosely correlated | -0.19% |
The RSI Indicator for SXTC moved out of oversold territory on May 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 39 similar instances when the indicator left oversold territory. In of the 39 cases the stock moved higher. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on May 29, 2026. You may want to consider a long position or call options on SXTC as a result. In of 109 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SXTC advanced for three days, in of 171 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
SXTC moved below its 50-day moving average on May 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for SXTC crossed bearishly below the 50-day moving average on May 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SXTC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
SXTC broke above its upper Bollinger Band on June 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SXTC entered a downward trend on June 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.381) is normal, around the industry mean (145.546). P/E Ratio (0.014) is within average values for comparable stocks, (94.721). SXTC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.701). SXTC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.034). P/S Ratio (0.444) is also within normal values, averaging (117.816).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SXTC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SXTC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.